Mon, August 23, 2021
Fri, August 20, 2021
Thu, August 19, 2021
Wed, August 18, 2021
Tue, August 17, 2021
Mon, August 16, 2021
Sun, August 15, 2021
Fri, August 13, 2021
Thu, August 12, 2021
Wed, August 11, 2021

Nathan Weinstein Maintained (ATAI) at Strong Buy with Increased Target to $27 on, Aug 17th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-27-on-aug-17th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Nathan Weinstein of Aegis Capital, Maintained "Atai Life Sciences N.V." (ATAI) at Strong Buy with Increased Target from $26 to $27 on, Aug 17th, 2021.

Nathan has made no other calls on ATAI in the last 4 months.



There are 7 other peers that have a rating on ATAI. Out of the 7 peers that are also analyzing ATAI, 1 agrees with Nathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Initiated at Hold and Held Target at $19 on, Tuesday, July 13th, 2021


These are the ratings of the 6 analyists that currently disagree with Nathan


  • Leonildo Delgado of "Baader Helvea" Initiated at Strong Buy and Held Target at $21 on, Wednesday, July 14th, 2021
  • Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $26 on, Tuesday, July 13th, 2021
  • Ritu Baral of "Cowen & Co." Initiated at Buy on, Tuesday, July 13th, 2021
  • Charles Duncan of "Cantor Fitzgerald" Initiated at Buy and Held Target at $45 on, Tuesday, July 13th, 2021
  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $35 on, Tuesday, July 13th, 2021
  • Judah Frommer of "Credit Suisse" Initiated at Buy and Held Target at $25 on, Tuesday, July 13th, 2021

Publication Contributing Sources